Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-related quality of life and patient-reported outcome measures in economic evaluation of urological technologies: challenges and opportunities.

BJU international·2026
Same author

Active surveillance for renal masses up to 2 cm: long-term oncological outcomes from a prospective multi-institutional study.

World journal of urology·2026
Same author

European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines.

European urology·2026
Same author

A Cost-Analysis and Micro-Costing Study of the Man Van Project: Comparing Prostate-Specific Antigen Testing Via a Nurse-Led Mobile Service with Primary Care.

PharmacoEconomics - open·2026
Same author

Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus Statement.

European urology oncology·2026
Same author

Evaluation of a point of care prostate-specific antigen blood test on a mobile outreach service.

Annals of clinical biochemistry·2025

Related Experiment Video

Updated: Jul 18, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

74

Mobile Health Solutions for Prostate Cancer Diagnostics-A Systematic Review.

Masood Moghul1,2, Walter Cazzaniga1, Fionnuala Croft1

  • 1Department of Urology, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.

Clinics and Practice
|August 25, 2023
PubMed
Summary

Mobile screening shows promise for prostate cancer detection, especially in high-risk men. Further research is needed, but targeted approaches may improve early diagnosis globally.

Keywords:
community settingmobile clinicprostate cancer

More Related Videos

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
06:55

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

5.6K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

856

Related Experiment Videos

Last Updated: Jul 18, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

74
Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
06:55

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

5.6K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

856

Area of Science:

  • Urology
  • Oncology
  • Public Health

Background:

  • Prostate cancer screening lacks global consensus due to conflicting mortality trial outcomes and limitations of the PSA test (prostate-specific antigen).
  • Prostate cancer disproportionately affects men of Black ethnicity and those from lower socioeconomic backgrounds, highlighting disparities in diagnosis and outcomes.
  • Existing screening methods face challenges with variability, specificity, and accessibility, particularly in diverse global settings.

Purpose of the Study:

  • To systematically review the existing evidence on mobile testing strategies for prostate cancer detection.
  • To evaluate the effectiveness and feasibility of mobile screening in identifying prostate cancer cases.

Main Methods:

  • A systematic review was conducted following Cochrane guidelines and the PRISMA statement.
  • Searched for all eligible mobile screening studies for prostate cancer published between 1973 and 2017.
  • Included studies screened 30,275 men across four continents.

Main Results:

  • Six studies met the eligibility criteria for the review.
  • Prostate cancer detection rates in the reviewed studies ranged from 0.6% to 8.2%.
  • Mobile screening detected varying rates of prostate cancer across different studies and time periods.

Conclusions:

  • Mobile targeted case finding may offer a viable solution for improving prostate cancer screening, particularly in underserved or high-risk populations.
  • Streamlined investigation and referral pathways, coupled with community awareness, are crucial for effective mobile prostate cancer screening.
  • Further research is warranted to optimize mobile screening strategies and address the global challenge of early prostate cancer diagnosis.